When: Fri., Oct. 23, 7 p.m. 2020
Psychedelic assisted psychotherapy is on track to be the next breakthrough in mental health care. The last decade has seen a renaissance in the field of psychedelic science—moving it from the fringes of the scientific world to the mainstream with startling speed, legitimizing the medical potential of psychedelic drugs. Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) has been a relentless advocate for developing legal contexts for the beneficial uses of psychedelics for decades.Join licensed psychotherapist and CIIS professor Gisele Fernandes for a fascinating conversation with Rick on the future of psychedelic assisted psychotherapy.
Price: Pay what you can